Avid Bioservices Inc (CDMO): I Translational Forum on Cancer Immunoth...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	86
Posts	12714
Boards Moderated	0
Alias Born	10/12/2010

biopharm

Re: None

Saturday, 01/31/2015 12:37:10 PM

Saturday, January 31, 2015 12:37:10 PM

I Translational Forum on Cancer Immunotherapy (FIT-Cancer-I)

March 13-14, 2015
Seville, Spain

SITC is partnerting with the Spanish Group for Immuno-Biological Thearpies in Cancer (GÉTICA) for the first educational program in the region focused upon translational cancer immunology.

GÉTICA aims to build a bridge between cancer immunologists and medical oncologists willing to better understand the basis of this change of therapeutic paradigm, in order to be competitive and creative in integrating immunotherapies in the therapeutic strategy of a disease, of a patient.

http://www.sitcancer.org/sitc-meetings/fit-cancer-i

--------------------------------------------------------

Spain leads the way in Sunrise Phase III

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!